How Heart Disease Treatment Has Evolved

Read Transcript

Heart transplants now have very good survival rates. I wouldn't say they're routinely done but they're done fairly commonly in most parts of the country, but the access to donor hearts is a problem. All the large centers including ours are somehow constrained by the availability of donor hearts.

The good news is advances and devices therapy has moved along. So, there are no technically mechanical hearts but there are essentially pumps that you can add on to existing hearts called vesicular system devices, the prevalence of coronary disease is going down. But, it's still the number one killer.

There's still I think one death from heart disease every three seconds or more. Coliory disease is a real traditional heart diseases of blockages in the coronary arteries seems to be on the decline, but [xx] relation is on the rise, it's growing faster than people predicted it would just based on the aging of the population.

So, it's one of those disease, it's more prevalent as you get older. Afib is abnormal, irregular, heart rhythm originating in the top chamber of the heart originating in the atria. And its the leading cause of stroke, and it can cause heart failure in symptoms. If you have coronary disease, or if you have a fib without any other risk of stroke namely you don't have diabetes or stroke then baby aspirin clearly prevents future events.

I think it's dramatically changed the way we approach cornary disease for sure. I mean it's such a simple thing and low coughs and highly effective, and if there is one treatment that people with coronary disease should have when they have a heart attack it's an aspirin. Well, aside from aspirin which most people wouldn't consider a technology but really have has totally revolutionized this.

The biggest thing is the infrastructure that hospitals have to put stent then within an hour or less. I think the jury is still out, and it's certainly hold promise, but forming heart from stem cells big leap from where we're now.